| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development, net | 1,171 | 2,111 | ||
| Sales, general and administrative | 2,690 | 1,612 | ||
| Operating loss | -3,861 | -3,723 | ||
| Other income (see note 3g) | - | 0 | ||
| Financing income, net | 284 | 223 | ||
| Net loss | -3,577 | -3,500 | ||
| Basic net loss per share | -0.07 | -0.1 | ||
| Basic weighted average common shares outstanding | 48,095,384 | 36,488,014 | ||
| Diluted net loss per share | -0.07 | -0.1 | ||
| Diluted weighted average common shares outstanding | 48,095,384 | 36,488,014 | ||
Microbot Medical Inc. (MBOT)
Microbot Medical Inc. (MBOT)